Investor Presentation H1 2023

35 Investor presentation First six months of 2023 Novo NordiskⓇ Novo Nordisk has a global manufacturing setup Local production All products API, fill and finish Russia API, fill and finish Fill and finish Product Supply value chain Fill and finish ㅎ Research and Development Manufacturing development API production API: Active Pharmaceutical Ingredient Iran Algeria Fill and finish Japan ເພີ້ມ ) ❖ : A ອອ பப்ப Filling / tableting Assembly and packaging Distribution (cold chain) Patients

View entire presentation